Philippines Health legislation Moves

24 July 1994

in the Philippines, leaders of Congress have given unanimous support to the Revised Medical Care Act of 1994 (HB 6976), which would establish a non-profit health maintenance organization system of health provision for all residents of the country.

Incorporating all existing programs into the new scheme, as well as including those residents who do not at present have health coverage, is expected to take three years. The Act also makes provision for preventive, promotive and educational aspects of public health.

A counterpart bill to HB 6976, the House bill, is the Senate's National Healthcare Act of 1994 (SB 1605), which would provide essential goods, health care and other social services at an affordable price to all Filipinos, and to provide free medical care to the very poor. This bill would establish a national Health Insurance Corporation to administer the national program, and would also expand the provision of medical benefits to cover outpatient care. The services of health care professionals, diagnostic, laboratory and other medical examination services, personal preventative services and prescription drugs and biologicals would all be provided for outpatients under the scheme.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight